Search results
Results from the WOW.Com Content Network
Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals International, Inc.) is an American-Canadian multinational specialty pharmaceutical company based in Laval, Quebec, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs, primarily for skin diseases, gastrointestinal disorders, eye health ...
J. Michael Pearson (born 1959) is a Canadian American [1] pharmaceutical company executive. He is the former chairman and CEO of Valeant Pharmaceuticals International [2] [3] after being ousted in the aftermath of a report on pharmaceutical pricing published by Citron Research in April 2016. [4]
Dayforce, Inc. Dayforce, Inc., formerly Ceridian, is a provider of human resources software and services with employees across its global footprint in the United States, Canada, Europe, Middle East, Africa ( EMEA ), and the Asia Pacific Japan (APJ) region. It is a publicly traded company on the New York Stock Exchange and Toronto Stock Exchange .
Venture capitalist slams 'useless' Google employees for draining the economy and ‘taking money away’ from the workforce’s retirement programs.
Valeant Pharmaceuticals International (NYS: VRX) reported earnings on Nov. 2. Here are the numbers you need to know. The 10-second takeaway For the quarter ended Sep. 30 (Q3), Valeant ...
Valeant Pharmaceuticals. Website. medicis.com. Medicis Pharmaceutical is a medical cosmetics company based in Bridgewater, New Jersey. It is a subsidiary of Valeant Pharmaceuticals, which acquired the company in 2012. [1] [2] Medicis is known for products such as Solodyn and Ziana for treating acne, and for Restylane and Dysport for treating ...
While much of the investing world was focusing on Valeant Pharmaceuticals' $8.7 billion acquisition of eye-care specialist Bausch & Lomb, the specialty pharmaceutical also reported it has received ...
Prior to joining Valeant, Papa was the chairman and CEO of Perrigo, an American manufacturer of private label over-the-counter pharmaceuticals, from 2006 to 2016. From December 2004 to October 2006, Papa was chairman and CEO of the pharmaceutical and technologies services of Cardinal Health, an Ohio health care services company.